Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Sunshine Biopharma, Inc. SBFM
$0.73
-$0.14 (-18.52%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
11735478.00000000
-
week52high
2.20
-
week52low
0.45
-
Revenue
4345603
-
P/E TTM
-1
-
Beta
-1.00242200
-
EPS
-1.58000000
-
Last Dividend
0.00000000
-
Next Earnings Date
05 апр 2023 г. в 12:00
Описание компании
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sebaaly Camille | A | 174465 | 30000 | 30 ноя 2022 г. |
| Sebaaly Camille | A | 144465 | 25000 | 03 июн 2022 г. |
| Slilaty Steve N. | D | 10000 | 990000 | 18 февр 2022 г. |
| Sebaaly Camille | A | 23893086 | 20000000 | 06 янв 2021 г. |
| Slilaty Steve N. | A | 23343461 | 20000000 | 06 янв 2021 г. |
| MERZOUKI ABDERRAZZAK | A | 23342500 | 20000000 | 06 янв 2021 г. |
| Slilaty Steve N. | A | 1000000 | 500000 | 17 июн 2020 г. |
| Slilaty Steve N. | A | 861209 | 323673 | 31 дек 2019 г. |
| Sebaaly Camille | D | 0 | 323673 | 31 дек 2019 г. |
| Slilaty Steve N. | A | 3343461 | 1300000 | 19 дек 2019 г. |
Новостная лента
4 Stocks Meeting GuruFocus' Value Screens in December
GuruFocus
05 дек 2022 г. в 17:46
As investors prepare for the holiday season, GuruFocus' value screeners identified several stocks that meet screening criteria based on key principles taught by Benjamin Graham, Peter Lynch and Berkshire Hathaway Inc. ( BRK.A , Financial)( BRK.B , Financial) co-managers Warren Buffett (Trades, Portfolio) and Charlie Munger (Trades, Portfolio). Four stocks that meet such criteria are Sunshine Biopharma Inc. ( SBFM , Financial), Regional Management Corp. ( RM , Financial), West Fraser Timber Co. Ltd.
10 Top Penny Stocks To Buy In June According To These Insiders Part 1
PennyStocks
07 июн 2022 г. в 14:54
Insiders are buying these penny stocks. The post 10 Top Penny Stocks To Buy In June According To These Insiders Part 1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Sunshine Biopharma: An Opportunity Knocking?
GuruFocus
09 мая 2022 г. в 11:03
Investors with a very high appetite for risk and seeking ultra-high-growth stocks can find potential opportunities within the pharma and biotech domain. Investing in development-stage biopharma companies is a typical high-risk, high-return bet that can end up providing multi-bagger returns if the company's research is successful.
Multiple Promising Treatments Accentuate the Bull Case for Sunshine Biopharma
InvestorPlace
26 апр 2022 г. в 08:13
SBFM stock is trading at a surprisingly low price, considering Sunshine Biopharma's demonstrably positive clinical results. The post Multiple Promising Treatments Accentuate the Bull Case for Sunshine Biopharma appeared first on InvestorPlace.
Why Is Sunshine Biopharma (SBFM) Stock Up Today?
InvestorPlace
25 апр 2022 г. в 13:37
Today, investors in Sunshine Biopharma and SBFM stock are getting a huge boost from news that the company filed a patent for a key drug. The post Why Is Sunshine Biopharma (SBFM) Stock Up Today?